AdvaMed Comments to OMB Deregulation RFI
A powerful op-ed from AdvaMed’s CEO explaining why tariffs could undermine U.S. medtech innovation, jobs, and patient care—and what must be done.
Legal
Learn more about our Legal work.
MedTech Compliance Bootcamp
Join AdvaMed & Porzio for this comprehensive compliance bootcamp to better understand the current medtech compliance framework.
U.S. National Security & Business: Navigating Sanctions, Export Controls, CFIUS, and Outbound Investment Under the Trump Administration
Akin will provide a CLE program covering the latest legal issues for inbound trade and investment, including the Trump Administration’s approach to trade policy and tariff issues, and strategies medical…
The Medical Innovation Agenda for the 119th Congress
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Smith v. Terumo BCT (Colorado Court of Appeals) March 6, 2025
AdvaMed® filed an amicus brief in the case of Smith v. Terumo BCT, Inc. The case concerns whether the court should create a cause of action for asymptomatic plaintiffs, permitting…
Navigating Inbound Trade & Investment: Strategies for Medtech in the Era of Tariffs & Trade Legal and Policy Shifts
Akin will provide a CLE program covering the latest legal issues for inbound trade and investment, including the Trump Administration’s approach to trade policy and tariff issues, and strategies medical…
AdvaMed® Comment Letter to OIG’s Annual Solicitation for Safe Harbors and Special Fraud Alerts
AdvaMed urges OIG to modernize Anti-Kickback Statute safe harbors and issue a new fraud alert to support value-based care and expand access to medical technologies.
AdvaMed® Recommendations to CMS Regarding Sunshine Reporting Audits
AdvaMed®, the world’s leading medtech trade association, communicated to Centers for Medicaid & Medicare Services (CMS) recommendations regarding administration of the Open Payments program.